+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Frontotemporal Lobar Degeneration-Modified Clinical Dementia Rating (FTLD-CDR) Scale and Frontotemporal Dementia Rating Scale (FRS) Correlation With Regional Brain Perfusion in a Series of FTLD Patients

Frontotemporal Lobar Degeneration-Modified Clinical Dementia Rating (FTLD-CDR) Scale and Frontotemporal Dementia Rating Scale (FRS) Correlation With Regional Brain Perfusion in a Series of FTLD Patients

Journal of Neuropsychiatry and Clinical Neurosciences 29(1): 26-30

Severity assessment scales for frontotemporal lobar degeneration (FTLD) have been recently introduced. In the present study, the authors examined whether the FTLD-modified Clinical Dementia Rating (FTLD-CDR) scale and the Frontotemporal Dementia Rating Scale (FRS) correlated with regional brain perfusion in Greek FTLD patients. A total of 47 behavioral variant frontotemporal dementia (bvFTD) patients and 33 primary progressive aphasia (PPA) patients were assessed for demographic data, cognitive reserve (CR), and severity of dementia and underwent brain single-photon emission computed tomography. Both scales were valid in the bvFTD group, predicting frontal lobe perfusion. In the PPA group, both scales were found to predict temporal hypoperfusion only after accounting for CR, which could imply a potential role for reserve in PPA patients.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 057905475

Download citation: RISBibTeXText

PMID: 27417072

DOI: 10.1176/appi.neuropsych.16020034

Related references

The FTLD-modified Clinical Dementia Rating scale is a reliable tool for defining disease severity in frontotemporal lobar degeneration: evidence from a brain SPECT study. European Journal of Neurology 17(5): 703-707, 2010

Clinical significance of lobar atrophy in frontotemporal dementia: application of an MRI visual rating scale. Dementia and Geriatric Cognitive Disorders 23(5): 334-342, 2007

Inclusions in frontotemporal lobar degeneration with TDP-43 proteinopathy (FTLD-TDP) and amyotrophic lateral sclerosis (ALS), but not FTLD with FUS proteinopathy (FTLD-FUS), have properties of amyloid. Acta Neuropathologica 125(3): 463-465, 2013

What's in a name? Neuronal intermediate filament inclusion disease (NIFID), frontotemporal lobar degeneration-intermediate filament (FTLD-IF) or frontotemporal lobar degeneration-fused in sarcoma (FTLD-FUS)?. Journal of Neurology Neurosurgery and Psychiatry 82(12): 1412-1414, 2011

Survival in two variants of tau-negative frontotemporal lobar degeneration: FTLD-U vs FTLD-MND. Neurology 65(4): 645-647, 2005

The relationship between oestrogen and executive functioning in ALS females with emerging Frontotemporal Lobar Degeneration (FTLD) supports a neuroendocrine model of FTLD attenuation. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 18(1-2): 74-85, 2017

The clinical dementia rating scale could be helpful in differentiating frontotemporal dementia from Alzheimer's disease. International Journal of Geriatric Psychiatry 26(8): 879-880, 2011

Disease Staging In Frontotemporal Dementia And Alzheimer'S Disease: The Contribution Of The Frontotemporal Dementia Rating Scale (Ftd-Frs) In A 12-Month Follow-Up Study. Alzheimer's & Dementia 13(7): P732-P733, 2017

Validity and Reliability of the Frontotemporal Dementia Rating Scale (FTD-FRS) for the Progression and Staging of Dementia in Brazilian Patients. Alzheimer Disease and Associated Disorders 32(3): 220-225, 2018

Rapidly progressive Fronto-temporal dementia (FTD) associated with Frontotemporal lobar degeneration (FTLD) in the presence of Fused in Sarcoma (FUS) protein: a rare, sporadic, and aggressive form of FTD. International Psychogeriatrics 29(10): 1743-1746, 2017

Utility of the Spanish version of the FTLD-modified CDR in the diagnosis and staging in frontotemporal lobar degeneration. Journal of the Neurological Sciences 344(1-2): 63-68, 2014

TMEM106B, a frontotemporal lobar dementia (FTLD) modifier, associates with FTD-3-linked CHMP2B, a complex of ESCRT-III. Molecular Brain 8(): 85-85, 2016

A visual [18F]FDG-PET rating scale for the differential diagnosis of frontotemporal lobar degeneration. European Archives of Psychiatry and Clinical Neuroscience 261(6): 433-446, 2011

Frontotemporal Lobar Degeneration (FTLD): Review and Update for Clinical Neurologists. Current Alzheimer Research 15(6): 511-530, 2018

Utility of clinical criteria in differentiating frontotemporal lobar degeneration (FTLD) from AD. Neurology 58(11): 1608-1615, 2002